Video
Author(s):
Melanie C. Majure, MD, assistant clinical professor in the Division of Hematology/Oncology and breast oncologist, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses unmet needs for patients with triple-negative breast cancer (TNBC).
Melanie C. Majure, MD, assistant clinical professor in the Division of Hematology/Oncology and breast oncologist, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses unmet needs for patients with triple-negative breast cancer (TNBC).
The biggest challenge facing metastatic TNBC are those patients who are not responding to the available therapies, explains Majure. Many of Majure’s patients frequently contact her because they are not responding to their therapy or their disease is progressing.
There needs to be an agent that targets specific molecular alterations for each patient’s specific tumor type, says Majure.